XTalks

JANUARY 29, 2025

Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drug delivery and drug-device combination product assembly in Rockford, Illinois.

Drug Delivery 52

Drug Delivery Production Packaging Packaging 52

Roots Analysis

FEBRUARY 18, 2022

The current landscape consists of more than 95 players that claim to offer oligonucleotide contract manufacturing services for research, diagnostic and therapeutic applications. It is worth highlighting that major share of the global oligonucleotide manufacturing capacity is installed in North America, primarily in the US. Web: [link].

Contract Manufacturing 52

Contract Manufacturing Manufacturing Drug Delivery Systems RNA 52

XTalks

MAY 30, 2023

The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. The Global ECG Patch Market The global ECG patch and holter monitor market , estimated to be around $13 billion and projected to grow at a 17.5

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

Delveinsight

NOVEMBER 29, 2020

Recent years started witnessing the emergence of novel treatment approaches that have been keeping the Retinal vein occlusion market in a hyped-up state. Looking at the potential of the pipeline therapies they hold once approved, pharmaceutical companies are charting out a seemingly exciting course in the market.

Marketing 52

Marketing Drug Delivery Pharma Companies Clinical Trials 52

Roots Analysis

FEBRUARY 26, 2023

Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drug delivery strategies to the long-acting drug delivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.

Drug Delivery 52

Drug Delivery Drug Delivery Systems Drugs Marketing 52

Roots Analysis

FEBRUARY 14, 2023

Presently, outsourcing of liposomes development and manufacturing related services has become a popular practice. Drug developers are actively outsourcing their operations to specialized repurposed-based service providers, which are known to have the required capabilities and expertise.

Development 52

Development Manufacturing Drug Delivery Systems Contract Manufacturing 52

Roots Analysis

FEBRUARY 16, 2022

In earlier times, container closure integrity testing was not regarded as an essential step in the process of manufacturing. The company developing drug product through such an intense process, use to consider container closure system only for packaging of the product. [1] Container Closure Integrity Testing Services Market.

Containment 52

Containment Packaging Packaging Drug Delivery Systems 52

Roots Analysis

MARCH 2, 2022

Owing to the numerous advantages of oral drug delivery, including ease of administration, minimal pain and risk of drug reaction, and self-administration, we are led to believe that the oral protein / peptide therapeutics market is anticipated to witness a significant growth in the coming future. Web: [link].

Protein 52

Protein Drugs Drug Delivery Drug Delivery Systems 52

XTalks

AUGUST 24, 2022

XTALKS WEBINAR: ISO 11608: Best Practices to De-Risk & Shorten Time to Market for Wearable Injectors. Register for this free webinar to learn the best practices to successfully incorporate 2022 ISO 11608 methodology to mitigate risk and accelerate time to market in combination product development.

Drug Delivery Systems 98

Drug Delivery Systems Drug Delivery Regulation Packaging 98

Roots Analysis

FEBRUARY 26, 2024

To learn more, please click New Frontiers Cancer Therapy market report. Types of Molecules and Regions Worldwide Overall, the growth is anticipated to be spread across multiple type of molecules and different geographical regions. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com.

Drug Delivery Systems 52

Drug Delivery Systems Marketing Drug Delivery Development 52

Roots Analysis

MARCH 3, 2022

Next Generation Complement Therapeutics – Current Market Landscape. The market is characterized by a mix of well-established and small firms. The pipeline features more than 190 next generation complement therapeutics that are either marketed / are currently being evaluated across different phases of development. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Marketing Immune Response Dermatology 52

FDA Law Blog

SEPTEMBER 19, 2023

The six-page statement explains that “Brand drug manufacturers may be harming generic competition through the improper listing of patents in the. But it is not always clear which types of patents are eligible for listing in the Orange Book.

Drugs 105

Drugs Branding Drug Delivery Systems Generic Drugs 105

Roots Analysis

MARCH 24, 2022

Metabolomics Services– Current Market Landscape. Considering the aforementioned factors, we are led to believe that the metabolomics services market is likely to witness rapid growth over the next few years. Therefore, unknown metabolite identification has a significant impact on omics research and biomarker discovery. Web: [link].

Clinical Research 52

Clinical Research Development Research Drug Delivery Systems 52

Roots Analysis

SEPTEMBER 13, 2023

Conjugation with a Variety of Molecular Conjugates and Labels The combination of the conjugates / labels with molecules ( proteins, peptides, antibodies and small molecules ) is being used abundantly for several applications, ranging from therapeutics and diagnostics to isolation and characterization of drug delivery systems.

Development 40

Development Antibody Protein Drug Delivery Systems 40

Roots Analysis

JANUARY 17, 2024

They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. Prefilled syringes are syringes that come pre-filled with a specific dose of medication.

Drug Delivery 40

Drug Delivery Contamination Drugs Production 40

Roots Analysis

FEBRUARY 26, 2024

Biologics constitute a majority of the top selling drugs and represent one of the fastest growing segments of the overall pharmaceutical industry. In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs Contract Manufacturing 52

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. The injectable drugs market is currently valued at around $532 billion.

Contamination 130

Contamination Packaging Packaging Manufacturing 130

Roots Analysis

MARCH 21, 2022

Subcutaneous biologics – current market landscape. Subcutaneous drug delivery systems – the helping hand for patients. Many of these antibody-based products are highly viscous and need to be administered using delivery systems in volumes that exceed the standard fill of a 1 mL prefilled syringe. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Drugs 52

Roots Analysis

FEBRUARY 20, 2022

Role of nanoparticles has been well established across various markets, such as healthcare, paint, consumer products ( including sunscreens, cosmetics ), aerospace and glass industries. However, manufacturing of these particles is a major challenge for players engaged in the industry.

Contract Manufacturing 52

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems 52

Roots Analysis

MARCH 13, 2022

Given the evident benefits of biologics over small molecule drugs (including high efficacy, target specificity and favorable safety profiles), the biopharmaceutical market is poised to witness continued and consistent growth over the next several years. As a result, the demand for biopharmaceutical excipients has grown considerably.

Manufacturing 52

Manufacturing Drug Delivery Marketing Drug Delivery Systems 52

Roots Analysis

OCTOBER 5, 2023

Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. There has been a rise in the development of polymers for biopharma with improved biocompatibility, biodegradability and functionality.

Manufacturing 40

Manufacturing Drug Delivery Systems Drug Delivery Packaging 40

Roots Analysis

FEBRUARY 18, 2022

Driven by lucrative investments, extensive R&D efforts and contributions from various big pharma players, the myeloid cell targeting therapeutics market is expected to grow at a steady pace. Myeloid Cells Targeting Therapeutics Market. Roots Analysis – MYELOID CELL TARGETING THERAPEUTICS: BUDDING THERAPY AGAINST CANCER.

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

Roots Analysis

FEBRUARY 13, 2023

As a result, there is an evident increase in the demand for mRNA manufacturing capacity. The key applications of mRNAs are below: Contract Manufacturing in mRNA Synthesis AND Manufacturing Service Domain The synthesis and manufacturing process of mRNA-based therapeutics / vaccines is complex and associated with several challenges.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

Drug Patent Watch

DECEMBER 19, 2024

This comprehensive guide will explore how pharmaceutical companies can leverage their drug patent portfolios to maximize value, maintain market dominance, and drive innovation. Understanding the Importance of Drug Patent Portfolios Drug patent portfolios are the lifeblood of pharmaceutical companies.

Drugs 92

Drugs Marketing Licensing Licensing 92

Roots Analysis

MAY 21, 2024

The LNPs can be monitored using various imaging modalities to confirm the delivery of siRNA to the target cells. This approach can enable synergistic effects, improved therapeutic outcomes, and reduced drug resistance.

Drug Delivery 40

Drug Delivery Drugs Gene Therapy Bioavailability 40